Previous Close | 43.99 |
Open | 44.16 |
Bid | 43.93 x 1000 |
Ask | 43.96 x 1000 |
Day's Range | 43.91 - 44.62 |
52 Week Range | 43.33 - 69.10 |
Volume | |
Avg. Volume | 15,803,131 |
Market Cap | 89.151B |
Beta (5Y Monthly) | 0.39 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.10 |
Earnings Date | Jul 26, 2024 |
Forward Dividend & Yield | 2.40 (5.46%) |
Ex-Dividend Date | Apr 04, 2024 |
1y Target Est | 48.62 |
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...